Health Care: Drugs

Seattle Genetics Inc (SGEN: NASDAQ)

$36.79 0.14 | 0.38%
11/26/14 - 04:00 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 269.26M 210.81M 94.78M 107.47M
Cost of Sales 10.65M 4.74M 3.12M 0.00
Gross Operating Profit 258.62M 206.08M 91.66M 107.47M
Selling, General, and Administrative Expenses 92.35M 84.30M 72.66M 29.26M
Research & Development 218.63M 170.30M 163.40M 146.41M
Operating Income before D & A (EBITDA) -52.36M -48.52M -144.39M -68.20M
Depreciation & Amortization 10.50M 8.73M 16.64M 6.99M
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net 341.00K 3.47M -7.64M 1.93M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -62.52M -53.78M -168.67M -73.26M
Interest Expense 0.00 0.00 0.00 0.00
Pre-Tax Income -62.52M -53.78M -168.67M -73.26M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -62.52M -53.78M -152.03M -66.26M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -62.52M -53.78M -152.03M -66.26M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -62.52M -53.78M -152.03M -66.26M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-62.52M -53.78M -152.03M -66.26M
Preferred Dividends
Net Income Available To Common -62.52M -53.78M -152.03M -66.26M
Basic EPS from Continuing Ops. -0.51 -0.46 -1.34 -0.66
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.51 -0.46 -1.34 -0.66
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.51 -0.46 -1.34 -0.66
Basic Normalized Net Income/Share -0.51 -0.46 -1.34 -0.66
EPS fr Continuing Ops. -0.51 -0.46 -1.34 -0.66
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.51 -0.46 -1.34 -0.66
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.51 -0.46 -1.34 -0.66
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.51 -0.46 -1.34 -0.66
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with SGEN

Latest SGEN Headlines from TheStreet

More Financial News for SGEN

Press Releases for SGEN

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter